| Title | Drugs and Therapy Perspectives |
| Abbreviation | Drugs Ther. Perspect. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (medical) (Q3) |
| h-index | 13 |
| Overall Rank/Ranking | 20631 |
| SCImago Journal Rank (SJR) | 0.188 |
| Impact Score | 0.49 |
| Publisher | Adis International Ltd |
| Country | United Kingdom |
| ISSN | 11791977, 11720360 |
| Best Quartile | Q3 |
| Coverage History | 1993-2023 |
Drugs and Therapy Perspectives is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q3). It is published by Adis International Ltd. The overall rank of Drugs and Therapy Perspectives is 20631. According to SCImago Journal Rank (SJR), this journal is ranked 0.188. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 13. The best quartile for this journal is Q3.
The ISSN of Drugs and Therapy Perspectives journal is 11791977, 11720360. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drugs and Therapy Perspectives is cited by a total of 196 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Drugs and Therapy Perspectives is 0.49, which is computed in 2024 as per its definition. Drugs and Therapy Perspectives IF is decreased by a factor of 0.59 and approximate percentage change is -54.63% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Drugs and Therapy Perspectives is 0.49. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.49 |
| 2022 | 1.08 |
| 2021 | 1.00 |
| 2020 | 0.17 |
| 2019 | 0.13 |
| 2018 | 0.23 |
| 2017 | 0.15 |
| 2016 | 0.10 |
| 2015 | 0.06 |
| 2014 | 0.07 |
Drugs and Therapy Perspectives has an h-index of 13. It means 13 articles of this journal have more than 13 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drugs and Therapy Perspectives is 11791977, 11720360. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drugs and Therapy Perspectives is 20631. According to SCImago Journal Rank (SJR), this journal is ranked 0.188. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.188 |
| 2022 | 0.162 |
| 2021 | 0.161 |
| 2020 | 0.127 |
| 2019 | 0.115 |
| 2018 | 0.131 |
| 2017 | 0.115 |
| 2016 | 0.117 |
| 2015 | 0.112 |
| 2014 | 0.105 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 20631 |
| 2022 | 21182 |
| 2021 | 20496 |
| 2020 | 25729 |
| 2019 | 25491 |
| 2018 | 23362 |
| 2017 | 26176 |
| 2016 | 25747 |
| 2015 | 26150 |
| 2014 | 27366 |
Drugs and Therapy Perspectives is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1993-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drugs and Therapy Perspectives is Drugs Ther. Perspect.. This abbreviation ('Drugs Ther. Perspect.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drugs and Therapy Perspectives latest impact IF is 0.49. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 1.08 (2022) and 0.06 (2015), respectively, in the last 10 years. Moreover, its average IS is 0.35 in the previous 10 years.
The Drugs and Therapy Perspectives has an SJR (SCImago Journal Rank) of 0.188, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.188 in 2023 and the lowest being 0.105 in 2014. Furthermore, the average SJR of the Drugs and Therapy Perspectives over the previous 10-year period stands at 0.35.
The latest h-index of the Drugs and Therapy Perspectives is 13.
The Drugs and Therapy Perspectives is published by the Adis International Ltd, with its country of publication being the United Kingdom.
The Drugs and Therapy Perspectives is currently ranked 20631 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 20496 in 2021 and its lowest position of 27366 in 2014.
The standard ISO4 abbreviation for the Drugs and Therapy Perspectives is Drugs Ther. Perspect..
Drugs and Therapy Perspectives is classified as a journal that the Adis International Ltd publishes.
The Drugs and Therapy Perspectives encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drugs and Therapy Perspectives is assigned the following International Standard Serial Numbers (ISSN): 11791977, 11720360.
The best quartile for the Drugs and Therapy Perspectives is Q3 (2023).
The Drugs and Therapy Perspectives coverage history can be summarized as follows: 1993-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Geriatric Physical Therapy | journal | 9578 | Lippincott Williams and Wilkins Ltd. | 47 | 1.23 |
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Canadian Journal of Education | journal | 18985 | Canadian Society for the Study of Education (CSSE) | 43 | 0.58 |
| International Journal of Research and Method in Education | journal | 5876 | Taylor and Francis Ltd. | 38 | 2.50 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18870 | Springer Medizin | 24 | 0.60 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.49 |
| 2022 | 1.08 |
| 2021 | 1.00 |
| 2020 | 0.17 |
| 2019 | 0.13 |
| 2018 | 0.23 |
| 2017 | 0.15 |
| 2016 | 0.10 |
| 2015 | 0.06 |
| 2014 | 0.07 |
